Testosterone To Blame for Market Madness?
Meet the newest contestant in the blame game.
But according to an article in Scientific American, the real culprit may be something entirely different: testosterone.
A recent study from Harvard University found that men with higher amounts of testosterone make riskier investments than men with lower levels. Could high levels of the hormone in CEOs have played a role in the current crisis? Anna Dreber, a co-author of the study, weighs in:
"Long-term, above-average testosterone levels may perhaps eventually lead to irrational risk-taking, and thus lower profits," Dreber said. "This is maybe what we see today."
Dreber's study was based on saliva samples from 98 Harvard students who were given $250 with which to invest. Results showed that men who had more masculine features invested 6% more of their money than their less masculine peers.
When men lose a competition (or money, for that matter), the amount of testosterone in their bodies decreases. Dreber says this could have played a roll in Monday's 777-point drop in the Dow.
"People have been losing and their testosterone levels may have decreased, and therefore, they are more risk averse," Dreber said.
Does this mean investors should be running out to their doctors for testosterone injections? Probably not. Side effects may include oily skin, acne and unfounded aggression. In times like these, staying cool may be more important that looking strong.
For more on how testosterone is the silent mover of the markets, check out Hoofy and Boo's always astute report.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Daily Recap Newsletter